Navigation Links
Hybrid Fuels, Inc. Announces New Business Strategy
Date:12/5/2011

FORT LAUDERDALE, Fla., Dec. 5, 2011 /PRNewswire/ -- Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today a reorientation of its main business activities and new strategic goals. 

The company will transform itself into a nutraceutical/pharmaceutical business venture that will focus on providing natural or nutraceutical solutions to medical conditions that would normally be treated or addressed with pharmaceutical drugs that are more damaging and can cause side effects that are sometimes even more harmful than the condition being treated.  The company's niche in the market place will be to provide nutraceutical alternatives and solutions to patients ranging from impotence, acne, cholesterol and many other common conditions. 

"Despite globalization, rocky economics and an uneasy healthcare system, the dietary supplement market continues to grow already boasting an estimated $25 billion in U.S. sales.  According to a survey conducted by Ipsos-Public Affairs for the Council for Responsible Nutrition, 65% of adult Americans (approx. 150 million) label themselves as supplement users.  The acquisition of EMG Marketing Solutions was the first step in implementing our new strategic goals focused on this evolving market.  EMB not only brings seasoned leadership in the nutraceutical industry but patented product formulations that are proven to help treat every day health conditions.  We look forward to announcing product lines in production over the next couple of weeks," stated Philip Schmidt, CEO of Hybrid Fuels, Inc.           

About Hybrid Fuels, Inc.

The company was incorporated in the state of Nevada in 1998 as Polo Equities.  It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. 

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.

CONTACT:
Hybrid Fuels, Inc. - 954-903-2993

 


'/>"/>
SOURCE Hybrid Fuels, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry
2. MetroSouth Surgeon Pioneers Hybrid Treatment of Large Hiatal Hernias and Reflux
3. Cardicas Automated Anastomosis Systems Featured at Advances In Robotic And Hybrid Coronary Revascularization Meeting
4. Frost & Sullivan Award Highlights Hybridyne Technologies Outstanding Technology Innovation
5. Philips and ACC Address the Growing Demand for Minimally Invasive Cardiology Interventions by Showcasing Hybrid OR Solutions at ACC 2010
6. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
7. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
8. WestPark Capital, Inc. Announces $2.6 Million IsoRay Offering
9. WestPark Capital Announces $2.6 Million IsoRay Offering
10. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
11. Physicians Capital Investments Announces Pedro Vergne-Marini, MD Named to Beckers ASC Review "350 People in the ASC Industry to Know"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
(Date:12/8/2016)... -- A new study by a pair of Geisinger Health ... to treat chronic pain is not only ineffective, it ... including death. Palliative care physicians Mellar ... M.D., authored the study which provides a review of ... was published in the December 2016 edition of Current ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
Breaking Medicine Technology:
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 , ... ... decreases in medical payments per workers’ compensation claim in 2013 and 2014, according to ... Workers Compensation Research Institute (WCRI) . , According to the study, medical payments per ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance Agency, ... Hamilton County, is embarking on a charity drive with the aim of generating ... for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts volunteers ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a locally owned ... clients in the northern Alabama and Georgia regions, is embarking on a charity ... Works has built a network of support and education facilities to develop and ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... Atlanta, Georgia (PRWEB) , ... ... ... announced today it has acquired Presence Technology, S.L. (“Presence”) for a purchase ... certain price adjustments and other considerations. Presence’s annual revenue is approximately $13.2 ...
Breaking Medicine News(10 mins):